Manufacturer record
Eurokem Laboratories Pvt ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Eurokem Laboratories Pvt ltd (Tamil Nadu) were declared Not of Standard Quality between October 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Eurokem Laboratories Pvt ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atorvastatin Tablets IP 10mg | AV26072Mfg 2026-04 · Exp 2027-09 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Atorvastatin Tablets IP 10mg | AC25002Mfg 2025-05 · Exp 2027-04 | The Sample does not meets the Specifications wrt. Dissolution Test as per IP.Dissolution | State Lab, DCL, TelanganaState lab | Jun 2026 |
| Telmisartan Tablets IP 40mg | TS24047Mfg 2024-10 · Exp 2025-12 | Dissolution of Telmisartan TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Telmisartan Tablets IP 40mg | TS24042Mfg 2024-10 · Exp 2025-12 | Dissolution of Telmisartan TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Aceclofenac Tablets IP 100mg | AF24009Mfg 2024-09 · Exp 2026-08 | Content of AceclofenacOther | DTL MaduraiState lab | Jun 2025 |
| Nifedipine Sustained Release Tablets IP 10 mg | NF24007Mfg 2024-08 · Exp 2026-01 | Sample does not conform to IP specification for Nifedipine Sustained Release Tablets with respect to the content of NifedipineOther | Drugs Testing Laboratory, Madurai-19State lab | May 2025 |
| Atorvastatin Tablets IP 10mg | AT24045Mfg 2024-08 · Exp 2026-01 | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Apr 2025 |
| Glimepiride Tablets I.P. 1mg | GP108Mfg 2021-04 · Exp 2023-03 | Dissolution & Related SubstancesDissolution | CDL KolkataCDSCO lab | Nov 2021 |
| Levodopa & Carbidopa Tablets IP | AU49Mfg 2018-12 · Exp 2020-11 | Description & Assay of Levodopa & CarbidopaAssay | CDTL ChennaiCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.